Nichol Ochsner | Vice President of Investor Relations |
Robert Finizio | Chief Executive Officer |
Dawn Halkuff | Chief Commercial Officer |
Mitchell Krassan | Chief Strategy & Performance Officer |
Jennifer Kim | Cantor Fitzgerald. |
Stacy Ku | Cowen & Company |
Annabel Samimy | Stifel |
Doug Tsao | H.C. Wainwright |
Ahu Demir | Noble Capital |
Dana Flanders | Guggenheim |
Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD First Quarter 2020 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions.
I would like to turn the conference over to our TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol?